HOUT-11. EXTENSIVE BRAINSTEM INFILTRATION, NOT MASS EFFECT, IS A COMMON FEATURE OF END-STAGE CEREBRAL GLIOBLASTOMAS

BACKGROUND: Progress in extending the survival of glioblastoma (GBM) patients has been slow, suggesting that preclinical and clinical trial approaches may not fully take into account the nature of this cancer. A better understanding of why GBM patient survival remains poor is critical to developing...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Drumm, Michael, Dixit, Karan, Grimm, Sean, Kumthekar, Priya, Lukas, Rimas, Raizer, Jeffrey, Kam, Kwok-Ling, McCord, Matthew, Sachdev, Sean, Kruser, Timothy, Steffens, Alicia, Javier, Rodrigo, McCortney, Kathleen, Horbinski, Craig
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Health Outcome Measures
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847675/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.476
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires